Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
KP Tissue Releases Fourth Quarter and Full Year 2024 Financial Results

In This Article:

KP Tissue Inc.
KP Tissue Inc.

Record revenue surpasses $2-billion mark in 2024 combined with strong Adjusted EBITDA in all four quarters

MISSISSAUGA, Ontario, March 05, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) reports the Q4 2024 and full year 2024 financial and operational results of KPT and Kruger Products Inc. (Kruger Products). Kruger Products is Canada's leading manufacturer of quality tissue products for the Consumer market (Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and BonterraTM) and the Away-From-Home (AFH) market and continues to grow in the U.S. Consumer tissue business with the White Cloud® brand and premium private label products. KPT currently holds a 12.5% interest in Kruger Products.

Kruger Products Q4 2024 Business and Financial Highlights

  • Revenue was $539.6 million in Q4 2024 compared to $482.3 million in Q4 2023, an increase of $57.3 million or 11.9%.

  • Adjusted EBITDA1 was $66.8 million in Q4 2024 compared to $61.2 million in Q4 2023, an increase of 9.2%.

  • Net loss was $13.7 million in Q4 2024 compared to net income of $16.5 million in Q4 2023, a decrease of $30.2 million.

  • Declared a quarterly dividend of $0.18 per share to be paid on April 15, 2025.

Kruger Products Full Year 2024 Financial Highlights

  • Revenue was $2,049.9 million in Fiscal 2024 compared to $1,873.0 million in Fiscal 2023, an increase of $176.9 million or 9.4%.

  • Adjusted EBITDA1 was $264.8 million in Fiscal 2024 compared to $238.6 million in Fiscal 2023, an increase of 11.0%.

  • Net income was $23.8 million in Fiscal 2024 compared to a net loss of $5.3 million in Fiscal 2023, an improvement in net income of $29.1 million.

“We are pleased with our financial performance in 2024, highlighted by record revenue of more than $2 billion and strong Adjusted EBITDA in all four quarters,” stated KP Tissue’s Chief Executive Officer, Dino Bianco. “We are particularly proud of our profitability results which were relatively stable in each quarter despite volatile pulp prices and input costs for most of the year. The fourth quarter culminated with revenue growth of 11.9% year-over-year to $539.6 million, driven by higher sales volume in the United States, favourable selling prices in Canada and a positive foreign exchange impact.”

“Following the successful start-up of our tissue plant at Sherbrooke in 2024, we are currently evaluating the construction of a new manufacturing facility that would contain a state-of-the-art TAD paper machine and three converting lines. The proposed plan supports our continued focus to grow revenue and our market share as well as offer high-quality tissue products to customers across North America. The current business uncertainty will require us to complete additional due diligence prior to making any announcement.”